正海生物 (300653)

Yantai Zhenghai Bio-Tech Co., Ltd.

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 18000.00
  • Circulating A-Shares(W): 18000.00
  • Earnings Per Share(RMB): 0.3700
  • Net Assets Per Share(RMB): 4.8582
  • Operating Revenue(W RMB): 27571.82
  • Total Profit(W RMB): 7318.25
  • Net Profit Attributable to Parent(W RMB): 6740.22
  • Net Profit Growth Rate(%): -46.10
  • Weighted Return on Equity(%): 7.6100
  • Operating Cash Flow Per Share(RMB): 0.4120
  • Undistributed Profit Per Share(RMB): 2.6432
  • Capital Reserve Per Share(RMB): 0.9412

2. Main Business

The main business covers:

  • Research, production, and sales of biological regenerative materials.
  • Building a full-chain business platform covering R&D, clinical trials, registration, production, quality assurance, and sales.

3. Company Basic Information

  • Company Name: Yantai Zhenghai Bio-Tech Co., Ltd.
  • Listing Date: 2017-05-16
  • Industry: Special Purpose Equipment Manufacturing
  • Address: No. 7 Nanjing Street, Yantai Economic and Technological Development Zone, Shandong Province, China
  • Website: www.zhbio.com
  • Company Profile: The Company was established as a joint stock company by approval of the Management Committee of Yantai Economic and Technological Development Zone and the People's Government of Shandong Province. It was converted from Zhenghai Bio-Tech Co., Ltd. by its seven shareholders, including Mihai Bo, Longwood, and CDH Vixin, using the audited net assets of the former company as of May 31, 2015. The Company obtained its Business License (Registration No.: 370600400015620) from the Yantai Administration for Industry and Commerce on June 26, 2015, with a registered capital of RMB 60 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Longwood Biotechnologies Inc. General Legal Person 1381.19 7.67
2 Jiaxing Zhenghai Venture Capital Partnership (Limited Partnership) General Legal Person 377.50 2.10
3 Orient Hongxin New Power Flexible Allocation Hybrid Securities Investment Fund A Fund 210.00 1.17
4 Orient Hongxin JD Big Data Flexible Allocation Hybrid Securities Investment Fund A Fund 98.84 0.55
5 Yongwin CSI All Share Medical Devices ETF Fund 66.82 0.37
6 Orient Hongxin Innovation Trend Hybrid Securities Investment Fund Fund 58.87 0.33

5. Concept Sectors

  • 3D Printing
  • Assisted Reproduction
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Bonus Share Potential
  • Specialized, Sophisticated, Distinctive, and Innovative SMEs
  • Micro & Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information